Imaging Research and Development Scientist at Eli Lilly and Company

Philadelphia, Pennsylvania, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Degree in physical or biological sciences or imaging-related field
Bachelor’s degree with minimum of 15 years’ experience, master’s with minimum of 12 years’ experience, or PhD in scientific field
Experience with in vitro assay development

Responsibilities

Establish and execute imaging research projects supporting oncology, neuroscience or other drug discovery and biomarker projects
Design and conduct novel binding assays, including radioligand binding assays
Characterize and purify biological targets
Collaborate with internal project teams, implement translatable imaging biomarker assays and ensure seamless translation of projects
Publish results of research projects as appropriate
Participate in extramural scientific organizations and attend scientific symposia as well as workshops in order to continue educational/professional development
Provide expertise for biological assay development for the discovery and characterization of novel PET imaging agents, with a focus on neuroscience or oncology imaging and other therapeutic areas
Work independently, coordinating experimental details of internal and external partnered projects, conducting experiments, performing data analysis, and presenting data to internal teams and the international scientific community
Other duties as assigned

Skills

Key technologies and capabilities for this role

molecular imagingPET imagingradioligand binding assaysbinding assaysassay developmentneuroscience imagingoncology imagingdata analysisdrug discoverybiomarker development

Questions & Answers

Common questions about this position

What are the basic qualifications for this Imaging Research and Development Scientist role?

Candidates need a degree in physical or biological sciences or imaging-related field, with a Bachelor’s degree plus minimum 15 years’ experience, a master’s plus minimum 12 years’ experience, or a PhD in a scientific field, along with experience in in vitro assay development.

What preferred skills are highlighted for this position?

Preferred skills include a PhD degree, experience in Oncology or Neuroscience preferably in molecular imaging, designing and executing novel biochemical/cellular/tissue assays including radioligand binding assays, and working with amyloidogenic proteins.

What is the salary or compensation for this role?

This information is not specified in the job description.

Is this position remote or does it require working at a specific location?

This information is not specified in the job description.

What does Eli Lilly's company culture emphasize?

Eli Lilly unites caring with discovery to make life better for people, puts people first, gives best effort to work, and seeks determined individuals who contribute to communities through philanthropy and volunteerism.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free